.png)
Pipo Saúde is a technology company.
A Pipo é uma corretora de saúde que cuida da gestão de saúde corporativa do começo ao fim do processo.
Pipo Saúde has raised $25.0M across 2 funding rounds.
Pipo Saúde has raised $25.0M in total across 2 funding rounds.
Pipo Saúde has raised $25.0M in total across 2 funding rounds.
Pipo Saúde's investors include ALLVP, Alpha4 ventures, Caffeinated Capital, Canary Ventures, Comal Ventures, Connolley, Endeavor Catalyst, Flourish Ventures, Graph Ventures, Homebrew, Khosla Ventures, Magma Partners.
Pipo Saúde is a Brazilian healthtech company that operates as a digital brokerage platform for corporate health benefits, enabling HR teams to purchase, manage, and optimize employee health plans, dental coverage, primary care, and wellness services in one place.[1][2][3] It serves companies by simplifying benefit management, providing data-driven insights, teleconsultations, health risk assessments, and tools like "Pipo Cuida" for preventive care and cost control, addressing Brazil's massive BRL 480B health benefits market—second only to payroll as a corporate expense—plagued by inefficient traditional brokers.[1][3][4] With over 100 corporate clients and 15,000 individuals served post its $4.6M seed in 2020 and $20M Series A, Pipo demonstrates strong growth momentum amid digital healthcare acceleration in Brazil.[1][5][6]
Founded in 2019 in São Paulo, Brazil (formerly Juno Saúde), Pipo Saúde was co-founded by Manoela Ribas Mitchell, who serves as CEO and has highlighted how COVID-19 accelerated Brazil's healthcare digital transformation.[1][2] The idea emerged to disrupt opaque, bureaucratic traditional brokers charging high margins (up to 40% EBITDA) without adding value, by leveraging technology for efficient benefit management and direct employee support.[3] Early traction came quickly with a $4.6M seed round in June 2020, enabling expansion to over 100 clients, fast onboarding (under an hour via HMO/PPO integrations), and a pivot to a comprehensive platform amid pandemic-driven demand.[1]
Pipo Saúde rides the wave of digital health transformation in Brazil, where COVID-19 fast-tracked adoption in a market historically lagging behind the US, fueled by rising corporate health costs and demand for efficient B2B insurtech solutions.[1][3] Timing aligns with a BRL 480B opportunity in corporate benefits, where tech disrupts entrenched brokers amid economic pressures on premiums and claims.[3][4] Market forces like preventive care mandates and employee wellness priorities favor Pipo, positioning it as a new distribution channel for providers while enhancing ecosystem efficiency through data and HR tools.[2][3]
Pipo Saúde is poised for scaled expansion in Brazil's healthtech boom, potentially capturing more of the underserved corporate segment with further funding (post-$20M Series A at $100M valuation) and international pilots.[1][4] Trends like AI-driven personalization, mental health integration, and regulatory pushes for cost transparency will shape its path, amplifying influence as a human-centric disruptor. As digital brokers redefine healthcare access, Pipo's platform could evolve into a full-stack wellness ecosystem, delivering sustained growth for a tech company simplifying employee health at scale.[1][2][3]
Pipo Saúde has raised $25.0M across 2 funding rounds. Most recently, it raised $20.0M Series A in July 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 1, 2021 | $20.0M Series A | ALLVP, Alpha4 ventures, Caffeinated Capital, Canary Ventures, Comal Ventures, Connolley, Endeavor Catalyst, Flourish Ventures, Graph Ventures, Homebrew, Khosla Ventures, Magma Partners, Mindset Ventures, monashees, NFX, Notable Capital, One Way Ventures, Qualcomm Ventures, Richmond Global Ventures, Thrive Capital, Valutia, Ed Baker, Justin Mateen, Karim Atiyeh, Mark Goines, Paulo Silveira, Sri Batchu | |
| Jun 1, 2020 | $5.0M Seed | monashees, Qualcomm Ventures |